
Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causin... Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -3.545 | -9.36715550271 | 37.845 | 38.9 | 34.02 | 425327 | 36.77376388 | CS |
4 | -6.7 | -16.3414634146 | 41 | 41.85 | 33.535 | 444597 | 37.46376457 | CS |
12 | -13.07 | -27.5913025121 | 47.37 | 47.42 | 33.535 | 479083 | 40.31883443 | CS |
26 | -15.28 | -30.8188785801 | 49.58 | 53.27 | 33.535 | 441093 | 43.87015317 | CS |
52 | -7.47 | -17.8836485516 | 41.77 | 53.27 | 29.24 | 517297 | 40.71701909 | CS |
156 | -5.01 | -12.744848639 | 39.31 | 53.27 | 9.6 | 607322 | 29.86334936 | CS |
260 | 1.38 | 4.19198055893 | 32.92 | 91.92 | 9.6 | 511168 | 34.33470281 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約